Literature DB >> 32313901

Ion channel dysfunction and altered motoneuron excitability in ALS.

Eric LoRusso1, James J Hickman1, Xiufang Guo1.   

Abstract

Dysregulated excitability is a hallmark of Amyotrophic Lateral Sclerosis (ALS) pathology both in ALS research models and in clinical settings. This primarily results from the dysfunction of Na+, K+, and Ca2+ ion channels responsible for maintaining neuronal thresholds and executing signal transduction or synaptic transmission. The exact dysfunction that each of these ion channel currents display in ALS pathology can vary between different ALS models, mainly induced pluripotent stem cell (iPSC) derived human motoneurons and ALS mouse models. Moreover, results can vary further across ALS mutations and between different developmental periods of these disease models. This review attempts to gather observations regarding ion channel dysfunction contributing to both hyperexcitable and hypoexcitable phenotypes in ALS motoneurons both in vivo and in vitro, so as to assess their potential as therapeutic targets.

Entities:  

Keywords:  ALS; Electrophysiology; Human; Ion Channels

Year:  2019        PMID: 32313901      PMCID: PMC7170321     

Source DB:  PubMed          Journal:  Neurol Disord Epilepsy J


  74 in total

1.  Axonal excitability properties in amyotrophic lateral sclerosis.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Clin Neurophysiol       Date:  2006-06-08       Impact factor: 3.708

Review 2.  Persistent Na-channels: origin and function. A review.

Authors:  T Kiss
Journal:  Acta Biol Hung       Date:  2008

3.  Selective degeneration of a physiological subtype of spinal motor neuron in mice with SOD1-linked ALS.

Authors:  Muhamed Hadzipasic; Babak Tahvildari; Maria Nagy; Minjuan Bian; Arthur L Horwich; David A McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

4.  Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.

Authors:  Dhruv Sareen; Jacqueline G O'Rourke; Pratap Meera; A K M G Muhammad; Sharday Grant; Megan Simpkinson; Shaughn Bell; Sharon Carmona; Loren Ornelas; Anais Sahabian; Tania Gendron; Leonard Petrucelli; Michael Baughn; John Ravits; Matthew B Harms; Frank Rigo; C Frank Bennett; Thomas S Otis; Clive N Svendsen; Robert H Baloh
Journal:  Sci Transl Med       Date:  2013-10-23       Impact factor: 17.956

Review 5.  Mitochondrial pathobiology in ALS.

Authors:  Lee J Martin
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

6.  Ca2+-permeable AMPA receptors and intracellular Ca2+ determine motoneuron vulnerability in rat spinal cord in vivo.

Authors:  Juan Carlos Corona; Ricardo Tapia
Journal:  Neuropharmacology       Date:  2007-01-20       Impact factor: 5.250

7.  Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.

Authors:  P Menon; N Geevasinga; M van den Bos; C Yiannikas; M C Kiernan; S Vucic
Journal:  Eur J Neurol       Date:  2017-04-24       Impact factor: 6.089

8.  Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.

Authors:  Alan Rembach; Bradley J Turner; Stephen Bruce; Irwin K Cheah; Rachel L Scott; Elizabeth C Lopes; Chrissandra J Zagami; Philip M Beart; Nam S Cheung; Steven J Langford; Surindar S Cheema
Journal:  J Neurosci Res       Date:  2004-08-15       Impact factor: 4.164

9.  Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis.

Authors:  Brigitte van Zundert; Marieke H Peuscher; Meri Hynynen; Adam Chen; Rachael L Neve; Robert H Brown; Martha Constantine-Paton; Mark C Bellingham
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

10.  Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS.

Authors:  María de Lourdes Martínez-Silva; Rebecca D Imhoff-Manuel; Aarti Sharma; C J Heckman; Neil A Shneider; Francesco Roselli; Daniel Zytnicki; Marin Manuel
Journal:  Elife       Date:  2018-03-27       Impact factor: 8.140

View more
  5 in total

1.  ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.

Authors:  Desiree M Baron; Adam R Fenton; Sara Saez-Atienzar; Anthony Giampetruzzi; Aparna Sreeram; Pamela J Keagle; Victoria R Doocy; Nathan J Smith; Eric W Danielson; Megan Andresano; Mary C McCormack; Jaqueline Garcia; Valérie Bercier; Ludo Van Den Bosch; Jonathan R Brent; Claudia Fallini; Bryan J Traynor; Erika L F Holzbaur; John E Landers
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

2.  Acute Colon Inflammation Triggers Primary Motor Cortex Glial Activation, Neuroinflammation, Neuronal Hyperexcitability, and Motor Coordination Deficits.

Authors:  Livia Carrascal; María D Vázquez-Carretero; Pablo García-Miranda; Ángela Fontán-Lozano; María L Calonge; Anunciación A Ilundáin; Carmen Castro; Pedro Nunez-Abades; María J Peral
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

3.  Exercise Physiology Impairments of Patients With Amyotrophic Lateral Sclerosis: Cardiopulmonary Exercise Testing Findings.

Authors:  Ji He; Jiayu Fu; Wei Zhao; Chuan Ren; Ping Liu; Lu Chen; Dan Li; Lequn Zhou; Lu Tang; Xiangyi Liu; Shan Ye; Xiaolu Liu; Yan Ma; Yixuan Zhang; Xinran Ma; Linjing Zhang; Gaoqi Zhang; Nan Li; Dongsheng Fan
Journal:  Front Physiol       Date:  2022-03-14       Impact factor: 4.566

4.  Survival motor neuron protein deficiency alters microglia reactivity.

Authors:  Guzal Khayrullina; Zaida A Alipio-Gloria; Marc-Olivier Deguise; Sabrina Gagnon; Lucia Chehade; Matthew Stinson; Natalya Belous; Elizabeth M Bergman; Fritz W Lischka; Jeremy Rotty; Clifton L Dalgard; Rashmi Kothary; Kristen A Johnson; Barrington G Burnett
Journal:  Glia       Date:  2022-04-04       Impact factor: 8.073

Review 5.  Breakdown of the central synapses in C9orf72-linked ALS/FTD.

Authors:  Layla T Ghaffari; Davide Trotti; Aaron R Haeusler; Brigid K Jensen
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.